GLP-1 analogs are more beneficial for type 2 diabetes

04/11/2012 | Medscape (free registration)

Biphasic insulin, basal insulin and glucagon-like peptide 1 analogs control blood glucose levels in people with type 2 diabetes, but GLP-1 analogs also encourage weight loss without raising the risk of hypoglycemia, a meta-analysis found. The results were published in Diabetes, Obesity and Metabolism.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Director, Payer Marketing
Avalere Health
Washington, DC